Why People Are Losing Faith in Healthcare
David Ricks, Chair and CEO of Eli Lilly, joins Scott to discuss the rise of GLP-1 drugs, the future of obesity treatment, and why America's healthcare system is facing a crisis of trust. They explore healthcare costs, addiction, unregulated peptides, pharmaceutical innovation, and the role AI could play in the next…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Prof G Pod with Scott Galloway
See all episodes →
Why America Can’t Solve Homelessness — with Anand Giridharadas
Who Profits When Everyone Is Recording? (ft. Kyla Scanlon)
Why Young Americans Are Rejecting Capitalism, and the Money Behind the Obesity Crisis
Similar episodes from other shows
More like The Prof G Pod with Scott Galloway →
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Healthcare is Broken—This Company Wants to Fix It
Ozempic’s Unknowns
Here's How the New Weight Loss Drugs Could Change Everything
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.